AmeriFlex Group’s PetMed Express PETS Stock Holding History

AmeriFlex Group’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$228	–	1602
2026 Q1	$228	Hold	100	–	–	﹤0.01%	1062
2025 Q4	$320	Buy	+100	New	+$251	﹤0.01%	1082

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPH

Steel Partners Holdings New York $78M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

AmeriFlex Group's PETS Position: Q2 2026 in Review

AmeriFlex Group sold out of PetMed Express (PETS) in Q2 2026, closing a stake of 100 shares — an estimated $228 sold.

AmeriFlex Group first reported a position in PETS in Q4 2025 and held it in 2 quarters. The position peaked at $320 in Q4 2025. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

AmeriFlex Group reported no remaining PetMed Express position as of Q2 2026 after selling out during the quarter.
AmeriFlex Group sold 100 PetMed Express shares in Q2 2026, an estimated $228.
AmeriFlex Group first reported a position in PetMed Express in Q4 2025 and held it in 2 quarters.
AmeriFlex Group's PetMed Express position peaked at $320 in Q4 2025.
50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.